Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Hans O Hallander"'
Autor:
Marjolein van Gent, Marieke J Bart, Han G J van der Heide, Kees J Heuvelman, Teemu Kallonen, Qiushui He, Jussi Mertsola, Abdolreza Advani, Hans O Hallander, Koen Janssens, Peter W Hermans, Frits R Mooi
Publikováno v:
PLoS ONE, Vol 6, Iss 5, p e20340 (2011)
To monitor changes in Bordetella pertussis populations, mainly two typing methods are used; Pulsed-Field Gel Electrophoresis (PFGE) and Multiple-Locus Variable-Number Tandem Repeat Analysis (MLVA). In this study, a single nucleotide polymorphism (SNP
Externí odkaz:
https://doaj.org/article/126e2aff87f34e2db415dff9ec1faff7
Autor:
Marieke J. Bart, Simon R. Harris, Abdolreza Advani, Yoshichika Arakawa, Daniela Bottero, Valérie Bouchez, Pamela K. Cassiday, Chuen-Sheue Chiang, Tine Dalby, Norman K. Fry, María Emilia Gaillard, Marjolein van Gent, Nicole Guiso, Hans O. Hallander, Eric T. Harvill, Qiushui He, Han G. J. van der Heide, Kees Heuvelman, Daniela F. Hozbor, Kazunari Kamachi, Gennady I. Karataev, Ruiting Lan, Anna Lutyńska, Ram P. Maharjan, Jussi Mertsola, Tatsuo Miyamura, Sophie Octavia, Andrew Preston, Michael A. Quail, Vitali Sintchenko, Paola Stefanelli, M. Lucia Tondella, Raymond S. W. Tsang, Yinghua Xu, Shu-Man Yao, Shumin Zhang, Julian Parkhill, Frits R. Mooi
Publikováno v:
mBio, Vol 5, Iss 2 (2014)
ABSTRACT Bordetella pertussis causes pertussis, a respiratory disease that is most severe for infants. Vaccination was introduced in the 1950s, and in recent years, a resurgence of disease was observed worldwide, with significant mortality in infants
Externí odkaz:
https://doaj.org/article/660166e9972641429cebdf1af2d9369b
Autor:
Qiushui He, Anna Lutyńska, Frits R. Mooi, Tine Dalby, Elisabeth Njamkepo, Karen A. Krogfelt, Nicole Guiso, Jussi Mertsola, Abdolreza Advani, Carl Heinz Wirsing von Könnig, Per Sandven, Hans O. Hallander, Norman K. Fry, Marion Riffelmann
Publikováno v:
Journal of Clinical Microbiology. 51:422-428
Between 1998 and 2009, Bordetella pertussis clinical isolates were collected during three periods, i.e., 1998 to 2001 ( n = 102), 2004 to 2005 ( n = 154), and 2007 to 2009 ( n = 140), from nine countries with distinct vaccination programs, i.e., Denm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::226640c9bd913069e354895c2f810698
https://doi.org/10.1128/jcm.02036-12
https://doi.org/10.1128/jcm.02036-12
Autor:
Hans O, Hallander
Publikováno v:
Lakartidningen. 113
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6cbb18c29dfb65ed05b2f6acb8f0a3e0
https://pubmed.ncbi.nlm.nih.gov/27003535
https://pubmed.ncbi.nlm.nih.gov/27003535
Publikováno v:
Vaccine. 30:3239-3247
Objectives: Shortly after pertussis vaccination was reintroduced in Sweden in 1996, an intensified pertussis disease surveillance programme was set up. In this study, we report on in-depth analyses of age-dose-number-specific incidences and the rate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a2f7b69b7da6576f0cc4cbcea7c7d8f
https://doi.org/10.1016/j.vaccine.2011.10.089
https://doi.org/10.1016/j.vaccine.2011.10.089
Publikováno v:
Expert Review of Clinical Pharmacology. 4:705-711
Pertussis is still poorly controlled in both adolescents and adults. As a result, an adolescent pertussis booster vaccine dose has already been implemented or decided on in many countries. The reasons for this have been twofold: a worrying increase o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d5aeee86135f15a17e515db93c3a778
https://doi.org/10.1586/ecp.11.55
https://doi.org/10.1586/ecp.11.55
Publikováno v:
Vaccine. 29:3438-3442
After introduction of a mono-component vaccine, containing only pertussis toxoid (PT), the incidence of pertussis was significantly higher in the Gothenburg area among children during the period October 1, 1997 until end of 2006 compared to the Rest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1eeba0d3f77d6587bca194e45fa502d7
https://doi.org/10.1016/j.vaccine.2011.02.070
https://doi.org/10.1016/j.vaccine.2011.02.070
Publikováno v:
APMIS. 117:912-922
The prevalence of IgG ELISA antibodies against pertussis toxin (anti-PT) was studied in two Swedish seroepidemiological studies. One was performed in 1997 when the new pertussis vaccination program was 1 year old (n = 3420). In 2007, when Pa vaccines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74d95bf4dbe354c2652982736889913e
https://doi.org/10.1111/j.1600-0463.2009.02554.x
https://doi.org/10.1111/j.1600-0463.2009.02554.x
Publikováno v:
APMIS. 117:797-807
Sera from 96 young children in a vaccine trial were analysed for kinetics of ELISA IgG anti-pertussis toxin (anti-PT) after a laboratory-verified pertussis infection. The antibody decay curves after infection were biphasic and similar in shape to tho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c185c3aef3940b3b1bb5725301f35272
https://doi.org/10.1111/j.1600-0463.2009.02530.x
https://doi.org/10.1111/j.1600-0463.2009.02530.x
Autor:
Hans O. Hallander, Lennart Gustafsson
Publikováno v:
Expert Review of Vaccines. 8:1303-1307
In the evaluation of vaccines, it can briefly be said that efficacy trials ask the question of how a vaccine works in well-controlled settings, while effectiveness studies, on the other hand, try t...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65b466c8838ed1c86eb8f7c06988a2ce
https://doi.org/10.1586/erv.09.88
https://doi.org/10.1586/erv.09.88